Heart failure with preserved ejection fraction (HFpEF) is a type of heart failure that affects the left side of the heart. It occurs when the lower left chamber of the heart, called the left ventricle ... The American Journal of Managed Care: Heart Failure Without a Reduced Ejection Fraction Bayer has received MHRA approval for Kerendia (finerenone) for adults in the UK with symptomatic chronic heart failure and a left ventricular ejection fraction of 40% or above.

Context Explanation

Th ... Science Daily: Preventing onset and development of heart failure with preserved ejection fraction An international team of researchers has discovered a natural mechanism that protects the heart from heart failure with preserved ejection fraction (HFpEF), a serious condition in need of effective ... Monthly Prescribing Reference: Heart Failure Patients With Ejection Fraction Improvement Rarely Withdrawn From Meds Heart failure (HF) substantially impacts the health and financial security of an increasing proportion of the US population. It worsens debility and quality of life and may lead to hospitalization and ...

Insight Material

PharmiWeb: Bayer receives MHRA approval for Kerendia® (finerenone) in adults with heart failure with LVEF ≥40%